Items Tagged ‘#drug-gene reactions’
October 18, 2016
Embrace Pharmacogenomics in Your Practice
By Sharon Rosen 
Article by Rachel Guibert, Public Affairs Currently, a population with a given disease generally receives the same therapy for all patients. Pharmacogenomics will change this ‘one-size-fits-all’ approach to drug treatments. Konstantinos Lazaridis, M.D., Eric Matey, Pharm.D., R.Ph., and Jeffrey Bishop, Pharm.D., M.S., B.C.P.P., are expecting a future practice reality in which clinicians will have every […]
Tags: #Dr. Jeffrey Bishop, #drug-gene reactions, #preemptive pharmacogenomics, center for individualized medicine, Dr. Eric Matey, Dr. Konstantinos Lazaridis, mayo clinic, PGx, pharmacogenomics
September 30, 2016
Consulting your genetic blueprint to find the right medication for you
By Sharon Rosen
Selecting the wrong medication for a patient can have serious implications. For example, if you have depression, the wrong medication could actually cause dangerous side effects that make you feel worse. In fact, researchers in the growing field of pharmacogenomics, which identifies drug-gene reactions, have already discovered that an individual’s genetic characteristics can influence how […]
Tags: #drug-gene reactions, #JAMA, #mental illness, #PrecisionMedicine, antidepressants, center for individualized medicine, depression, Dr. Mark Frye, individualized medicine, mayo clinic, pharmacogenomics, Psychiatry
August 26, 2016
Three Key Takeaways from Pharmacogenomics Discussion in San Diego
By Sharon Rosen
Article by Susan Buckles, Public Affairs Christopher Grilli, Pharm.D. and Adrijana Kekic, Pharm.D., of the Mayo Clinic Center for Individualized Medicine in Arizona shared their expertise in pharmacogenomics (PGx) at the Precision Medicine Leaders Summit 2016 earlier this month. They led a robust roundtable discussion at the summit in San Diego on PGx among physicians […]
Tags: #CIMCon16, #Dr. Adrijana Kekic, #Dr. Christopher Grilli, #drug-gene reactions, center for individualized medicine, mayo clinic, PGx, pharmacogenomics, Precision Leaders Medicine Summit 2016